NuCana Plc (NCNA)
1.43
+0.04
(+2.88%)
USD |
NASDAQ |
Sep 03, 16:00
1.43
0.00 (0.00%)
After-Hours: 20:00
NuCana Net Income (Annual) : -38.68M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -38.68M |
| December 31, 2024 | -24.27M |
| December 31, 2023 | -34.35M |
| December 31, 2022 | -39.44M |
| December 31, 2021 | -55.75M |
| December 31, 2020 | -39.35M |
| Date | Value |
|---|---|
| December 31, 2019 | -27.32M |
| December 31, 2018 | -18.45M |
| December 31, 2017 | -29.73M |
| December 31, 2016 | -8.140M |
| December 31, 2015 | -8.133M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | -8.413M |
| Mereo BioPharma Group Plc | -41.98M |
| BioNTech SE | -1.282B |
| Silence Therapeutics Plc | -88.61M |
| Autolus Therapeutics Plc | -288.20M |